Quality Improvement in Breast Cancer Testing

In 2018, fifteen ACCC Cancer Program Members were awarded grants from Pfizer, Inc. for quality improvement (QI) projects focused on improving the quality of care for patients with breast cancer. Grantees planned and implemented projects that supported increasing the rates of guideline-concordant BRCA testing for this patient population. Hear from grantees about their findings and experiences in successfully orchestrating a QI project and expanding BRCA testing for eligible patients with breast cancer. Learn about open opportunities to participate in an ACCC-supported QI project, then see how ACCC's online self-assessment tools can help identify areas of improvement at your program or practice.

Zohra Ali-Khan Catts, MS, LCGC, Director, Cancer Genetic Counseling, ChristianaCare

Jennifer R. Klemp, PhD, MPH, Professor of Medicine, Division of Medical Oncology, University of Kansas Medical Center; Director, Cancer Survivorship; Co-Program Leader, Cancer Prevention and Control, Cancer Risk Counseling, University of Kansas Cancer Center

Charles H. Shelton, MD, Radiation Oncologist; Chair of Cancer Committee; Breast Program Leader, The Outer Banks Hospital

This webinar is part of the “Quality Improvement in Breast Cancer Through BRCA Testing” educational program and is supported by a grant from Pfizer, Inc.